EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Current Perspectives on the Use of Adjuvant Pembrolizumab for Hepatocellular Carcinoma

Anna Mingazzini, Daniel Riado Minguez iD, Ylenia Babini iD, Elia Gigante, Mohamed Bouattour iD

Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-17

DOI: 10.2147/jhc.s613651 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Anna Mingazzini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

immune checkpoint inhibitionliver oncologyminimal residual diseaseperioperative treatmentrecurrence biomarkerstumor recurrence

Autor:innen und Institutionen

  • Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Unité Fonctionnelle Oncologie Hépatique et Innovation Thérapeutique, Hôpital Beaujon, AP-HP, Clichy, France.
  • Department of Gastroenterology and Hepatology Rey Juan Carlos University Hospital, C/ Gladiolo sn, Mostoles, Madrid, 28933, Spain.
  • Service d'Hépato-Gastroentérologie et de Cancérologie Digestive, CHU Reims, Reims, France.
  • INSERM U1149, Centre de Recherche sur l'Inflammation (CRI), Paris, France.

ORCID-Profile: Daniel Riado Minguez, Ylenia Babini, Mohamed Bouattour

Zitieren

APA

Mingazzini, A., Riado Minguez, D., Babini, Y., Gigante, E., & Bouattour, M. (2026). Current Perspectives on the Use of Adjuvant Pembrolizumab for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 13, 1-17. https://doi.org/10.2147/jhc.s613651

Vancouver

Mingazzini A, Riado Minguez D, Babini Y, Gigante E, Bouattour M. Current Perspectives on the Use of Adjuvant Pembrolizumab for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-17. doi:10.2147/jhc.s613651

BibTeX
@article{Mingazzini2026,
  author = {Mingazzini, Anna and Riado Minguez, Daniel and Babini, Ylenia and Gigante, Elia and Bouattour, Mohamed},
  title = {Current Perspectives on the Use of Adjuvant Pembrolizumab for Hepatocellular Carcinoma},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--17},
  doi = {10.2147/jhc.s613651}
}
Kostenlos starten →